FIELD: biotechnology.
SUBSTANCE: invention relates to new conjugates of antibodies with drugs, and can be used in medicine. The invention discloses conjugates of antibodies capable of binding to tumor antigens with fragment-drugs that are splicing modulators, wherein the conjugated fragments are interconnected via a linker.
EFFECT: invention may be used in the treatment of neoplastic disorders, in particular cancer.
52 cl, 10 ex, 27 tbl, 26 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODY-DRUG CONJUGATES CONTAINING HERBOXYDIENE-BASED SPLICING MODULATOR, AND METHODS OF USE THEREOF | 2019 |
|
RU2820607C2 |
| ANTI-SEZ6 ANTIBODIES AND METHODS FOR USING THEM | 2013 |
|
RU2691698C2 |
| COMPOSITIONS AND METHODS RELATING TO DRUG CONJUGATES WITH ANTI-CD19 ANTIBODIES | 2019 |
|
RU2806333C2 |
| MULTISPECIFIC ANTIBODIES, THEREOF ANALOGUES, COMPOSITIONS AND METHODS | 2010 |
|
RU2580038C2 |
| CONJUGATES OF ANTIBODIES AND DRUGS CHARACTERIZED IN HIGH IN VIVO TOLERANCE | 2018 |
|
RU2764031C2 |
| PROLACTIN RECEPTOR BINDING PROTEINS AND THEIR USE | 2013 |
|
RU2664463C2 |
| ANTIBODY-DRUG CONJUGATE, INTERMEDIATE FOR ITS PRODUCTION, METHOD OF ITS PRODUCTION AND ITS USE | 2020 |
|
RU2800137C1 |
| ANTIBODY-DRUG CONJUGATES BASED ON ERIBULIN AND APPLICATION METHODS | 2017 |
|
RU2754369C2 |
| ANTI-TAT226 ANTIBODIES AND IMMUNOCONJUGATES | 2007 |
|
RU2448980C2 |
| PEPTIDOMIMETIC COMPOUNDS AND THEIR CONJUGATES OF ANTIBODIES WITH DRUGS | 2014 |
|
RU2689388C1 |
